undamentalytics Newsletter

Foehr Matthew W: insider trades

Chief executive, Officer, Director at 4 companies we cover. 20 open-market purchases and 21 sales not made under a pre-set plan, reported from July 1, 2013 to April 7, 2026.

Would copying Foehr Matthew W’s purchases have beaten the S&P 500?

Too few purchases to judge. Only 7 purchases have 12 months of prices after the report; we judge insiders once they have 20. The figures below can swing a long way on a handful of trades. Buying each purchase the day after it was reported, an equal amount each, and holding it 12 months or until they reported a sale would have turned $10,000 on July 2, 2013 into $9,298 by November 2, 2026, −0.6% a year. The copy held shares only 35% of the time, so the fair comparison is the S&P 500 on those same days with Treasury bills otherwise: $19,662, +5.2% a year (the S&P 500 held throughout made $58,663, +14.2% a year). Beta against the index was 0.33. Twelve months after each report, the average purchase was −15.8% against the S&P 500 (median −56.4%), and 43% beat it. Measured from the trade date, the insider’s own timing, the average was −11.8%. After their sales, the shares moved −3.3% against the index over 12 months on average (a negative figure means selling was the right call); 75% trailed it.

With 296 insiders tested, some will look skilled or unskilled by chance alone: when we replaced each insider’s stocks with random companies bought on the same days, about 5.7 cleared the bar ahead and 23.3 behind. One record on its own proves little.

$0$20.0k$40.0k$60.0k 2013201520172019202120232025 $58.7k$19.7k$9.3k
Copying Foehr Matthew WS&P 500, same days investedS&P 500, held throughout $10,000 copying Foehr Matthew W’s open-market purchases from July 2, 2013, before costs and taxes, marked weekly. Each purchase gets the same starting stake, bought at the close of the first trading day after the report and sold 12 months later or the day after a reported sale of that stock; uninvested money earns the Treasury bill rate. “Same days invested” holds the S&P 500 only on the days the copy held shares, Treasury bills otherwise.
Return a year, copying
−0.6%
S&P 500, same days invested
+5.2% (held throughout +14.2%)
Time in shares
35%
Sharpe ratio (S&P 500)
0.06 (0.76)
Biggest drop (S&P 500)
−71% (−34%)
Market sensitivity (beta)
0.33
Purchases copied
7

Trade by trade

Foehr Matthew W: trades against the S&P 500 afterwards
MeasuredTrades countedAverage vs S&P 500MedianWent the right wayYearst-statisticp-valueEvidence
Purchases, 3 months after the report 7 −9.7% −17.6% 43% 6 −0.93 0.40 No reliable evidence
Purchases, 6 months after the report 7 −10.2% −21.9% 29% 6 −0.50 0.64 No reliable evidence
Purchases, 12 months after the report 7 −15.8% −56.4% 43% 6 −0.37 0.73 No reliable evidence
Purchases, 12 months after the trade 7 −11.8% −47.6% 43% 6 −0.24 0.82 No reliable evidence
Sales, 3 months after the report 13 +5.6% +7.6% 31% 7 0.80 0.45 No reliable evidence
Sales, 12 months after the report 12 −3.3% −8.8% 75% 6 −0.75 0.49 No reliable evidence
Sales, 12 months after the trade 12 −5.6% −11.3% 75% 6 −0.96 0.38 No reliable evidence

“Average vs S&P 500” is the stock’s return including dividends minus the index’s over the same dates, from the close on the first trading day after the report, or from the close on the trade date. Only windows that have finished are counted. For sales, a negative figure means the stock lagged after it was sold, so selling was the right call (green). “Went the right way” is the share of purchases that beat the index, or of sales that trailed it. The t-statistic uses one average per year of reports, because one person’s trades bunch into the same stock and weeks, and needs trades in at least four different years; the p-value comes from the t distribution with that number of years (with four years, a t of 2 has p = 0.14). “Some evidence” means p under 5%, “strong evidence” p under 1% over at least six years.

Companies traded

CompanyTitle on the latest filingPurchasesSalesFirst reportLatest report
Omniab, Inc. OABI President and CEO108November 9, 2022April 7, 2026
Ligand Pharmaceuticals Inc LGND President and COO311July 1, 2013May 13, 2022
Viking Therapeutics, Inc. VKTX —42April 13, 2016January 5, 2026
FF EAI Robotics Ecosystem Inc. FFR —30January 11, 2016August 20, 2018

Trades and what followed

Moves are against the S&P 500; green means the trade went the insider’s way.

ReportedTradedCompanyTradeValue3 months after report12 months after report12 months after trade
April 7, 2026April 7, 2026 OABI Sale $28,674 not yetnot yetnot yet
February 18, 2026February 18, 2026 OABI Sale $52,742 not yetnot yetnot yet
February 17, 2026February 17, 2026 OABI Sale $35,282 not yetnot yetnot yet
January 5, 2026January 2, 2026 VKTX Sale $561,760 +6.3%not yetnot yet
December 9, 2025December 8, 2025 OABI Sale $26,785 not yetnot yetnot yet
April 7, 2025April 7, 2025 OABI Sale $38,764 not yetnot yetnot yet
February 19, 2025February 18, 2025 OABI Sale $123,033 not yetnot yetnot yet
January 22, 2025January 21, 2025 OABI Sale $135,468 not yetnot yetnot yet
December 10, 2024December 9, 2024 OABI Sale $56,308 not yetnot yetnot yet
May 28, 2024May 24, 2024 OABI Purchase $1,060,800 not yetnot yetnot yet
March 25, 2024March 22, 2024 OABI Purchase $1,167,750 −30.7%−61.8%−63.1%
December 13, 2023December 12, 2023 OABI Purchase $1,010,000 −17.6%−63.1%−52.9%
November 13, 2023November 10, 2023 OABI Purchase $405,650 not yetnot yetnot yet
August 15, 2023August 14, 2023 OABI Purchase $246,600 −23.0%−57.4%−47.6%
June 12, 2023June 9, 2023 OABI Purchase $519,800 not yetnot yetnot yet
May 15, 2023May 12, 2023 OABI Purchase $1,496,000 not yetnot yetnot yet
December 14, 2022December 12, 2022 OABI Purchase $565,500 not yetnot yetnot yet
December 1, 2022November 30, 2022 OABI Purchase $1,017,000 not yetnot yetnot yet
November 9, 2022November 9, 2022 OABI Purchase $276,000 not yetnot yetnot yet
May 13, 2022May 13, 2022 LGND Purchase $206,900 +16.2%+40.3%+40.0%
May 3, 2022May 2, 2022 VKTX Purchase $111,150 not yetnot yetnot yet
November 12, 2021November 11, 2021 LGND Sale $1,819,303 −20.4%−9.3%−6.7%
August 5, 2021August 4, 2021 LGND Sale $969,483 +37.3%−4.5%−6.3%
June 10, 2021June 10, 2021 VKTX Purchase $113,800 +3.2%−56.4%−56.0%
February 5, 2021February 4, 2021 LGND Sale $7,878,582 −46.5%−56.5%−50.9%
June 30, 2020June 30, 2020 VKTX Sale $95,550 −26.2%−51.4%−57.8%
August 20, 2018August 17, 2018 FFR Purchase $40,292 not yetnot yetnot yet
May 11, 2018May 10, 2018 LGND Sale $1,488,722 +32.8%−43.1%−39.4%
February 27, 2018February 23, 2018 LGND Sale $832,823 +25.3%−22.0%−23.1%
August 10, 2017August 9, 2017 LGND Sale $777,811 +9.5%+80.2%+71.8%
May 18, 2017May 18, 2017 FFR Purchase $11,160 not yetnot yetnot yet
May 15, 2017May 12, 2017 LGND Sale $630,676 +7.6%+52.9%+44.1%
March 3, 2017March 2, 2017 LGND Sale $711,220 +2.8%+39.8%+40.8%
November 15, 2016November 15, 2016 VKTX Purchase $15,730 not yetnot yetnot yet
August 9, 2016August 5, 2016 LGND Sale $1,526,750 −13.4%−4.0%−17.1%
April 13, 2016April 13, 2016 VKTX Purchase $24,800 not yetnot yetnot yet
March 17, 2016March 17, 2016 LGND Sale $618,880 +12.0%−8.3%−6.2%
January 11, 2016January 8, 2016 FFR Purchase $21,320 not yetnot yetnot yet
July 1, 2014June 30, 2014 LGND Purchase $18,742 −27.6%+47.3%+54.7%
December 13, 2013December 12, 2013 LGND Sale $320,400 +45.5%−12.9%−15.9%
July 1, 2013June 28, 2013 LGND Purchase $18,384 +12.0%+40.2%+42.1%

Open-market purchases and sales of at least $10,000 in companies we cover, from SEC Form 4 filings; sales made under a pre-set Rule 10b5-1 plan are not shown. “Not yet” means the window has not finished or the share price was under $5 at entry. These are the shares’ moves after each trade: they say nothing about why Foehr Matthew W traded and do not suggest the use of non-public information. How every insider compares · the insider trading backtest.